REG - CVS Group plc - Block Listing Application

CVSAnnouncement

05/05/2023 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230505:nRSE5744Ya&default-theme=true

RNS Number : 5744Y  CVS Group plc  05 May 2023

5 May 2023

 

CVS Group plc

 

("CVS" or the "Company")

 

Block Listing Application

 

CVS, one of the UK's leading providers of integrated veterinary services,
announces that an application has been made to the Financial Conduct Authority
and the London Stock Exchange for the admission of 120,000 of its ordinary
shares of 0.2p each in the Company ("Ordinary Shares") to trading on AIM.

 

The Ordinary Shares will be reserved under a block listing and will be issued
in connection with the grant, vesting and/or exercise of awards under the
terms of the Company's Long Term Incentive Plans ("LTIP").  It is expected
that the majority of the shares reserved under the block listing will satisfy
the exercise of options in connection with the next LTIP vesting on 2 October
2023.

When issued, the Ordinary Shares under the block listing will rank pari passu
with the Company's existing issued Ordinary Shares. It is anticipated that the
block-listed shares will be admitted on 11 May 2023.

 

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

   Letaba
Rimell
+44 (0)7789 151 644

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services
in the UK, with practices in the Netherlands and the Republic of Ireland. CVS
is focused on providing high quality clinical services to its customers and
their animals, with outstanding and dedicated clinical teams and support
colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including
eight specialist referral hospitals and 37 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").

The Group employs c.8,500 personnel, including c.2,200 veterinary surgeons
and c.3,100 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSUPUGAAUPWUMA